Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5806795 | Current Opinion in Virology | 2014 | 6 Pages |
Abstract
Vaccination remains the most effective means to prevent morbidity and mortality caused by influenza epidemics and pandemics. Live attenuated influenza vaccine (LAIV) has been proven to be effective in preventing influenza with broad cross reactivity to drifted strains. Owing to the sophisticated nature of the influenza vaccine production process, the time needed to develop high yield LAIV strains for vaccine production and product release remains a constant challenge. This review summarizes LAIV production process with highlights on the experiences gained during the past decade generating seasonal and pandemic LAIV seeds by reverse genetics strategy.
Related Topics
Life Sciences
Immunology and Microbiology
Virology
Authors
Hong Jin, Zhongying Chen,